Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Patient Participation | 59 | 2024 | 1447 | 7.960 |
Why?
|
Decision Making | 73 | 2024 | 3953 | 6.890 |
Why?
|
Decision Support Techniques | 46 | 2024 | 2008 | 5.730 |
Why?
|
Osteoarthritis, Hip | 9 | 2022 | 409 | 3.250 |
Why?
|
Health Knowledge, Attitudes, Practice | 27 | 2024 | 4055 | 2.320 |
Why?
|
Patient Education as Topic | 22 | 2024 | 2337 | 2.160 |
Why?
|
Osteoarthritis, Knee | 9 | 2022 | 1251 | 2.120 |
Why?
|
Physician-Patient Relations | 14 | 2024 | 3269 | 1.810 |
Why?
|
Patient Preference | 16 | 2024 | 946 | 1.730 |
Why?
|
Mastectomy | 16 | 2022 | 1861 | 1.700 |
Why?
|
Breast Neoplasms | 43 | 2024 | 21206 | 1.670 |
Why?
|
Patient Satisfaction | 16 | 2024 | 3488 | 1.660 |
Why?
|
Psychometrics | 13 | 2021 | 3063 | 1.610 |
Why?
|
Patient-Centered Care | 11 | 2021 | 1444 | 1.500 |
Why?
|
Spinal Stenosis | 5 | 2020 | 259 | 1.320 |
Why?
|
Colorectal Neoplasms | 8 | 2024 | 6974 | 1.260 |
Why?
|
Arthroplasty, Replacement, Hip | 4 | 2022 | 1417 | 1.070 |
Why?
|
Arthroplasty, Replacement, Knee | 4 | 2022 | 1389 | 1.060 |
Why?
|
Early Detection of Cancer | 15 | 2024 | 3239 | 1.060 |
Why?
|
Multicenter Studies as Topic | 3 | 2024 | 1737 | 0.930 |
Why?
|
Communication | 11 | 2024 | 3905 | 0.920 |
Why?
|
Informed Consent | 7 | 2019 | 1010 | 0.820 |
Why?
|
Orthopedic Procedures | 2 | 2021 | 1279 | 0.730 |
Why?
|
Genetic Counseling | 2 | 2024 | 635 | 0.720 |
Why?
|
Quality Assurance, Health Care | 4 | 2016 | 2176 | 0.700 |
Why?
|
Tracheostomy | 1 | 2024 | 430 | 0.700 |
Why?
|
Mammaplasty | 5 | 2022 | 1268 | 0.680 |
Why?
|
Knowledge | 1 | 2021 | 178 | 0.680 |
Why?
|
Orthopedics | 2 | 2018 | 906 | 0.650 |
Why?
|
Choice Behavior | 9 | 2024 | 848 | 0.630 |
Why?
|
Caregivers | 4 | 2024 | 2302 | 0.590 |
Why?
|
Reproducibility of Results | 17 | 2023 | 20227 | 0.590 |
Why?
|
Goals | 4 | 2011 | 717 | 0.590 |
Why?
|
Humans | 139 | 2024 | 768166 | 0.580 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2023 | 3729 | 0.570 |
Why?
|
Cross-Sectional Studies | 25 | 2024 | 26379 | 0.560 |
Why?
|
Quality of Health Care | 10 | 2018 | 4310 | 0.510 |
Why?
|
Referral and Consultation | 6 | 2021 | 3620 | 0.510 |
Why?
|
Female | 86 | 2024 | 397192 | 0.480 |
Why?
|
Aortic Valve Stenosis | 2 | 2024 | 2032 | 0.460 |
Why?
|
Middle Aged | 57 | 2024 | 223492 | 0.460 |
Why?
|
Health Care Surveys | 6 | 2017 | 2434 | 0.450 |
Why?
|
Aged | 44 | 2024 | 171504 | 0.450 |
Why?
|
Patients | 3 | 2016 | 908 | 0.450 |
Why?
|
Checklist | 2 | 2018 | 840 | 0.450 |
Why?
|
Physicians | 5 | 2023 | 4598 | 0.430 |
Why?
|
Quality Indicators, Health Care | 2 | 2021 | 1805 | 0.430 |
Why?
|
Depression | 3 | 2022 | 8230 | 0.410 |
Why?
|
Coronary Angiography | 3 | 2018 | 4541 | 0.400 |
Why?
|
Lumbar Vertebrae | 4 | 2018 | 1885 | 0.400 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2024 | 10399 | 0.400 |
Why?
|
Directive Counseling | 2 | 2015 | 171 | 0.400 |
Why?
|
Quality Improvement | 2 | 2017 | 3857 | 0.400 |
Why?
|
Genetic Testing | 3 | 2024 | 3591 | 0.390 |
Why?
|
Health Services Research | 3 | 2015 | 1815 | 0.390 |
Why?
|
Quality of Life | 12 | 2022 | 13490 | 0.370 |
Why?
|
Diskectomy | 1 | 2012 | 203 | 0.350 |
Why?
|
Attitude of Health Personnel | 5 | 2017 | 3929 | 0.350 |
Why?
|
Professional-Patient Relations | 2 | 2008 | 724 | 0.350 |
Why?
|
Radial Artery | 1 | 2012 | 188 | 0.350 |
Why?
|
Emotions | 3 | 2020 | 2767 | 0.350 |
Why?
|
Survivors | 3 | 2012 | 2381 | 0.340 |
Why?
|
Arthroplasty, Replacement | 1 | 2013 | 311 | 0.340 |
Why?
|
Mastectomy, Segmental | 4 | 2017 | 974 | 0.330 |
Why?
|
Focus Groups | 4 | 2024 | 1460 | 0.330 |
Why?
|
Catheterization, Peripheral | 1 | 2012 | 347 | 0.310 |
Why?
|
Internal Medicine | 1 | 2016 | 1064 | 0.300 |
Why?
|
Angina Pectoris | 1 | 2012 | 957 | 0.300 |
Why?
|
Femoral Artery | 1 | 2012 | 829 | 0.290 |
Why?
|
Male | 43 | 2024 | 364719 | 0.290 |
Why?
|
Physicians, Primary Care | 2 | 2024 | 624 | 0.280 |
Why?
|
Advance Directives | 1 | 2009 | 249 | 0.280 |
Why?
|
Emergency Medicine | 1 | 2016 | 1223 | 0.280 |
Why?
|
Estrogen Replacement Therapy | 1 | 2014 | 1209 | 0.280 |
Why?
|
Ovarian Neoplasms | 1 | 2024 | 4916 | 0.280 |
Why?
|
Health Literacy | 3 | 2024 | 466 | 0.280 |
Why?
|
Adult | 40 | 2024 | 223646 | 0.280 |
Why?
|
Cooperative Behavior | 3 | 2016 | 1514 | 0.270 |
Why?
|
Pilot Projects | 9 | 2024 | 8741 | 0.270 |
Why?
|
Primary Health Care | 5 | 2024 | 4746 | 0.260 |
Why?
|
Menopause | 1 | 2014 | 1656 | 0.250 |
Why?
|
Colonoscopy | 2 | 2024 | 1409 | 0.250 |
Why?
|
Perception | 4 | 2024 | 1209 | 0.240 |
Why?
|
Data Collection | 4 | 2023 | 3327 | 0.240 |
Why?
|
Emergency Service, Hospital | 2 | 2016 | 7951 | 0.240 |
Why?
|
Socioeconomic Factors | 6 | 2018 | 7852 | 0.230 |
Why?
|
Maine | 1 | 2024 | 146 | 0.230 |
Why?
|
Time Factors | 4 | 2024 | 40218 | 0.230 |
Why?
|
United States | 18 | 2024 | 73039 | 0.220 |
Why?
|
Comparative Effectiveness Research | 2 | 2019 | 714 | 0.220 |
Why?
|
Patient Acceptance of Health Care | 2 | 2021 | 3231 | 0.220 |
Why?
|
Aged, 80 and over | 11 | 2024 | 59629 | 0.220 |
Why?
|
Education, Medical, Graduate | 1 | 2016 | 2420 | 0.220 |
Why?
|
Qualitative Research | 3 | 2024 | 3140 | 0.210 |
Why?
|
Neoplasms | 6 | 2023 | 22371 | 0.210 |
Why?
|
Cardiology | 1 | 2014 | 1702 | 0.210 |
Why?
|
Decision Theory | 2 | 2015 | 27 | 0.210 |
Why?
|
Mass Screening | 5 | 2024 | 5458 | 0.200 |
Why?
|
Academic Medical Centers | 4 | 2023 | 2784 | 0.200 |
Why?
|
Pamphlets | 2 | 2014 | 71 | 0.200 |
Why?
|
Massachusetts | 4 | 2024 | 8890 | 0.200 |
Why?
|
Information Dissemination | 1 | 2011 | 1143 | 0.200 |
Why?
|
Curriculum | 1 | 2016 | 3782 | 0.200 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2024 | 640 | 0.200 |
Why?
|
Delivery of Health Care | 3 | 2023 | 5367 | 0.190 |
Why?
|
Video Recording | 2 | 2019 | 976 | 0.190 |
Why?
|
Neoplasm Metastasis | 2 | 2009 | 4912 | 0.190 |
Why?
|
Heart Valve Prosthesis Implantation | 2 | 2024 | 1566 | 0.190 |
Why?
|
Occult Blood | 1 | 2022 | 199 | 0.190 |
Why?
|
Program Development | 3 | 2016 | 1300 | 0.190 |
Why?
|
Research Design | 2 | 2015 | 6211 | 0.190 |
Why?
|
Surgical Procedures, Operative | 1 | 2013 | 1932 | 0.190 |
Why?
|
Delphi Technique | 3 | 2018 | 891 | 0.190 |
Why?
|
Algorithms | 2 | 2020 | 14164 | 0.190 |
Why?
|
Chemotherapy, Adjuvant | 7 | 2022 | 3556 | 0.190 |
Why?
|
Reminder Systems | 1 | 2024 | 388 | 0.180 |
Why?
|
Pediatrics | 1 | 2016 | 3629 | 0.180 |
Why?
|
Osteoarthritis | 2 | 2018 | 1072 | 0.170 |
Why?
|
Chemoprevention | 1 | 2002 | 327 | 0.170 |
Why?
|
Clinical Competence | 1 | 2016 | 4858 | 0.170 |
Why?
|
Independent Living | 1 | 2024 | 584 | 0.170 |
Why?
|
Anxiety | 4 | 2024 | 4672 | 0.170 |
Why?
|
Interviews as Topic | 4 | 2024 | 2741 | 0.170 |
Why?
|
Intention | 1 | 2022 | 347 | 0.160 |
Why?
|
Disclosure | 2 | 2024 | 755 | 0.160 |
Why?
|
Acute Coronary Syndrome | 1 | 2012 | 2194 | 0.160 |
Why?
|
Electronics | 1 | 2020 | 317 | 0.160 |
Why?
|
California | 2 | 2014 | 1438 | 0.160 |
Why?
|
Feasibility Studies | 4 | 2012 | 5315 | 0.160 |
Why?
|
Esthetics | 2 | 2010 | 328 | 0.150 |
Why?
|
Social Support | 2 | 2024 | 2193 | 0.150 |
Why?
|
Videotape Recording | 2 | 2011 | 335 | 0.150 |
Why?
|
Home Care Services | 1 | 2024 | 659 | 0.150 |
Why?
|
Prospective Studies | 9 | 2024 | 54926 | 0.150 |
Why?
|
Opioid-Related Disorders | 2 | 2024 | 2188 | 0.140 |
Why?
|
Patient Care Planning | 1 | 2002 | 905 | 0.140 |
Why?
|
Longitudinal Studies | 4 | 2021 | 14783 | 0.130 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2022 | 3251 | 0.130 |
Why?
|
Health Policy | 2 | 2011 | 2698 | 0.130 |
Why?
|
Confidence Intervals | 3 | 2010 | 2923 | 0.130 |
Why?
|
Utilization Review | 1 | 2017 | 381 | 0.130 |
Why?
|
Trust | 1 | 2020 | 532 | 0.130 |
Why?
|
Hip Fractures | 1 | 2024 | 997 | 0.130 |
Why?
|
Consumer Health Information | 1 | 2018 | 215 | 0.130 |
Why?
|
Expert Testimony | 1 | 2017 | 266 | 0.130 |
Why?
|
Patient Care Team | 2 | 2017 | 2523 | 0.120 |
Why?
|
Program Evaluation | 2 | 2016 | 2507 | 0.120 |
Why?
|
Aortic Valve | 1 | 2024 | 1970 | 0.120 |
Why?
|
Primary Prevention | 1 | 2002 | 1188 | 0.120 |
Why?
|
Aortic Valve Insufficiency | 1 | 2019 | 577 | 0.120 |
Why?
|
Leiomyoma | 2 | 2009 | 644 | 0.120 |
Why?
|
Body Image | 1 | 2019 | 646 | 0.120 |
Why?
|
Educational Status | 3 | 2010 | 2515 | 0.120 |
Why?
|
Cardiovascular Diseases | 3 | 2022 | 15662 | 0.120 |
Why?
|
Politics | 1 | 2021 | 822 | 0.110 |
Why?
|
Evaluation Studies as Topic | 1 | 2016 | 1627 | 0.110 |
Why?
|
Spinal Diseases | 1 | 2018 | 561 | 0.110 |
Why?
|
Educational Measurement | 3 | 2010 | 1260 | 0.110 |
Why?
|
Research Subjects | 1 | 2015 | 249 | 0.110 |
Why?
|
Fear | 2 | 2019 | 1495 | 0.100 |
Why?
|
Sweating | 1 | 2014 | 155 | 0.100 |
Why?
|
Workflow | 1 | 2017 | 860 | 0.100 |
Why?
|
Social Class | 2 | 2020 | 2008 | 0.100 |
Why?
|
Pandemics | 2 | 2022 | 8748 | 0.100 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2024 | 2043 | 0.100 |
Why?
|
Costs and Cost Analysis | 1 | 2018 | 1667 | 0.100 |
Why?
|
Risk Assessment | 9 | 2024 | 24315 | 0.100 |
Why?
|
Down Syndrome | 1 | 2020 | 919 | 0.100 |
Why?
|
Child | 4 | 2024 | 80917 | 0.100 |
Why?
|
Colonic Neoplasms | 1 | 2023 | 2541 | 0.100 |
Why?
|
Prostatic Neoplasms | 3 | 2024 | 11101 | 0.100 |
Why?
|
Hospitals, General | 1 | 2016 | 809 | 0.090 |
Why?
|
Patient Discharge | 1 | 2024 | 3479 | 0.090 |
Why?
|
Treatment Outcome | 8 | 2024 | 65371 | 0.090 |
Why?
|
Defibrillators, Implantable | 1 | 2021 | 1498 | 0.090 |
Why?
|
Medicare | 2 | 2024 | 6809 | 0.090 |
Why?
|
San Francisco | 1 | 2011 | 166 | 0.090 |
Why?
|
Health Personnel | 4 | 2023 | 3385 | 0.090 |
Why?
|
Hot Flashes | 1 | 2014 | 330 | 0.090 |
Why?
|
Retrospective Studies | 7 | 2024 | 81762 | 0.090 |
Why?
|
Neoplasm Staging | 4 | 2018 | 11244 | 0.090 |
Why?
|
Health Status | 2 | 2021 | 4091 | 0.090 |
Why?
|
Cohort Studies | 4 | 2019 | 41754 | 0.090 |
Why?
|
Observation | 1 | 2012 | 310 | 0.090 |
Why?
|
Random Allocation | 1 | 2014 | 2396 | 0.080 |
Why?
|
Social Values | 2 | 2011 | 224 | 0.080 |
Why?
|
Diagnostic Self Evaluation | 1 | 2011 | 228 | 0.080 |
Why?
|
Peripheral Arterial Disease | 1 | 2021 | 1304 | 0.080 |
Why?
|
Dementia | 1 | 2024 | 2740 | 0.080 |
Why?
|
Heart Valve Diseases | 1 | 2017 | 1030 | 0.080 |
Why?
|
Practice Guidelines as Topic | 4 | 2018 | 7454 | 0.080 |
Why?
|
Stress, Psychological | 1 | 2024 | 4530 | 0.080 |
Why?
|
Mammography | 1 | 2019 | 2433 | 0.080 |
Why?
|
Insurance Claim Review | 1 | 2013 | 744 | 0.080 |
Why?
|
Attitude to Health | 1 | 2017 | 2025 | 0.070 |
Why?
|
Health Plan Implementation | 1 | 2011 | 338 | 0.070 |
Why?
|
Logistic Models | 3 | 2011 | 13290 | 0.070 |
Why?
|
Neurosurgical Procedures | 1 | 2018 | 2076 | 0.070 |
Why?
|
Lung Neoplasms | 2 | 2021 | 13586 | 0.070 |
Why?
|
Tumor Burden | 3 | 2017 | 1906 | 0.070 |
Why?
|
Education | 1 | 2008 | 533 | 0.060 |
Why?
|
Cognition | 1 | 2023 | 7073 | 0.060 |
Why?
|
Internationality | 1 | 2011 | 1008 | 0.060 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2017 | 11878 | 0.060 |
Why?
|
Angiogenesis Inhibitors | 1 | 2015 | 2056 | 0.060 |
Why?
|
Internal-External Control | 1 | 2006 | 348 | 0.060 |
Why?
|
Tape Recording | 1 | 2024 | 77 | 0.060 |
Why?
|
Prostatic Hyperplasia | 1 | 2008 | 516 | 0.060 |
Why?
|
Internet | 3 | 2017 | 3110 | 0.060 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 3436 | 0.060 |
Why?
|
Quality Control | 1 | 2006 | 836 | 0.060 |
Why?
|
Uncertainty | 2 | 2024 | 769 | 0.060 |
Why?
|
Coronary Artery Bypass | 1 | 2013 | 2191 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2019 | 9419 | 0.050 |
Why?
|
Control Groups | 1 | 2023 | 107 | 0.050 |
Why?
|
Data Interpretation, Statistical | 1 | 2013 | 2709 | 0.050 |
Why?
|
Community Health Services | 1 | 2008 | 659 | 0.050 |
Why?
|
Clinical Trials, Phase III as Topic | 2 | 2017 | 879 | 0.050 |
Why?
|
Community Health Centers | 1 | 2006 | 469 | 0.050 |
Why?
|
Needs Assessment | 1 | 2008 | 1141 | 0.050 |
Why?
|
Germany | 1 | 2024 | 883 | 0.050 |
Why?
|
Denmark | 1 | 2024 | 776 | 0.050 |
Why?
|
Lung | 1 | 2021 | 10099 | 0.050 |
Why?
|
Healthcare Disparities | 1 | 2018 | 3415 | 0.050 |
Why?
|
Health Surveys | 1 | 2012 | 4057 | 0.050 |
Why?
|
Health Care Reform | 1 | 2011 | 1256 | 0.050 |
Why?
|
Child, Preschool | 1 | 2024 | 42669 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 2 | 2023 | 18065 | 0.050 |
Why?
|
Sweden | 1 | 2024 | 1382 | 0.050 |
Why?
|
Odds Ratio | 2 | 2010 | 9669 | 0.050 |
Why?
|
Comprehension | 1 | 2006 | 638 | 0.050 |
Why?
|
Genes, BRCA2 | 2 | 2015 | 593 | 0.050 |
Why?
|
Bariatric Surgery | 1 | 2011 | 1001 | 0.050 |
Why?
|
Australia | 1 | 2024 | 1265 | 0.050 |
Why?
|
Appointments and Schedules | 1 | 2024 | 443 | 0.040 |
Why?
|
Genes, BRCA1 | 2 | 2015 | 755 | 0.040 |
Why?
|
Multivariate Analysis | 2 | 2010 | 12077 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2017 | 4887 | 0.040 |
Why?
|
Risk Factors | 6 | 2022 | 74944 | 0.040 |
Why?
|
Netherlands | 1 | 2024 | 2277 | 0.040 |
Why?
|
Certification | 2 | 2017 | 420 | 0.040 |
Why?
|
Depressive Disorder, Major | 1 | 2017 | 4818 | 0.040 |
Why?
|
Canada | 1 | 2024 | 2130 | 0.040 |
Why?
|
Reproduction | 1 | 2023 | 646 | 0.040 |
Why?
|
Communication Barriers | 1 | 2002 | 419 | 0.040 |
Why?
|
Intermittent Claudication | 1 | 2021 | 305 | 0.040 |
Why?
|
Coronary Artery Disease | 1 | 2018 | 6568 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2017 | 39348 | 0.040 |
Why?
|
Adjuvants, Immunologic | 1 | 2022 | 998 | 0.040 |
Why?
|
Terminal Care | 1 | 2009 | 1770 | 0.030 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2004 | 934 | 0.030 |
Why?
|
Benchmarking | 1 | 2003 | 1057 | 0.030 |
Why?
|
Personal Satisfaction | 1 | 2020 | 643 | 0.030 |
Why?
|
Morbidity | 1 | 2021 | 1755 | 0.030 |
Why?
|
Internship and Residency | 1 | 2016 | 5953 | 0.030 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2003 | 1099 | 0.030 |
Why?
|
Social Stigma | 1 | 2021 | 788 | 0.030 |
Why?
|
Risk | 2 | 2021 | 9613 | 0.030 |
Why?
|
General Surgery | 2 | 2010 | 1720 | 0.030 |
Why?
|
Lymphatic Metastasis | 2 | 2015 | 2914 | 0.030 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2022 | 1536 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2000 | 2862 | 0.030 |
Why?
|
Models, Statistical | 1 | 2008 | 5107 | 0.030 |
Why?
|
Models, Biological | 1 | 2008 | 9495 | 0.030 |
Why?
|
Neoadjuvant Therapy | 1 | 2004 | 2907 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2018 | 1443 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2019 | 2125 | 0.020 |
Why?
|
Parity | 1 | 2015 | 931 | 0.020 |
Why?
|
Reference Values | 1 | 2019 | 4938 | 0.020 |
Why?
|
Adaptation, Psychological | 1 | 2002 | 2663 | 0.020 |
Why?
|
Cyclophosphamide | 1 | 2017 | 2227 | 0.020 |
Why?
|
Placebos | 1 | 2015 | 1667 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2022 | 8542 | 0.020 |
Why?
|
Heart Valve Prosthesis | 1 | 2019 | 1468 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2022 | 3474 | 0.020 |
Why?
|
Doxorubicin | 1 | 2017 | 2234 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2002 | 3706 | 0.020 |
Why?
|
Forecasting | 2 | 2011 | 2945 | 0.020 |
Why?
|
Vaccination | 1 | 2022 | 3437 | 0.020 |
Why?
|
Paclitaxel | 1 | 2017 | 1733 | 0.020 |
Why?
|
Decision Support Systems, Clinical | 1 | 2018 | 1178 | 0.020 |
Why?
|
Medical Oncology | 1 | 2000 | 2346 | 0.020 |
Why?
|
Health Behavior | 1 | 2019 | 2650 | 0.020 |
Why?
|
Psychotherapy | 1 | 2017 | 1654 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2010 | 15832 | 0.020 |
Why?
|
Sex Factors | 1 | 2021 | 10632 | 0.020 |
Why?
|
Self Efficacy | 1 | 2011 | 643 | 0.020 |
Why?
|
Pain | 1 | 2022 | 5100 | 0.020 |
Why?
|
Prognosis | 2 | 2008 | 30010 | 0.020 |
Why?
|
Survival Analysis | 1 | 2019 | 10101 | 0.020 |
Why?
|
Antidepressive Agents | 1 | 2017 | 2913 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 2015 | 2603 | 0.010 |
Why?
|
Age Factors | 1 | 2021 | 18412 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2018 | 3533 | 0.010 |
Why?
|
Prescription Drugs | 1 | 2010 | 635 | 0.010 |
Why?
|
Survival Rate | 1 | 2017 | 12840 | 0.010 |
Why?
|
Recurrence | 1 | 2015 | 8509 | 0.010 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2004 | 361 | 0.010 |
Why?
|
Infant | 1 | 2024 | 36535 | 0.010 |
Why?
|
Young Adult | 2 | 2021 | 60066 | 0.010 |
Why?
|
Pregnancy | 1 | 2023 | 30256 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2008 | 14729 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2015 | 12465 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 2008 | 2253 | 0.010 |
Why?
|
Adolescent | 2 | 2021 | 89169 | 0.010 |
Why?
|
Mutation | 2 | 2015 | 30238 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2004 | 1791 | 0.010 |
Why?
|
Research | 1 | 2006 | 1979 | 0.010 |
Why?
|
Body Mass Index | 1 | 2015 | 13053 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2007 | 3573 | 0.010 |
Why?
|
Software | 1 | 2008 | 4478 | 0.010 |
Why?
|
Comorbidity | 1 | 2008 | 10590 | 0.010 |
Why?
|
Disease Progression | 1 | 2004 | 13671 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2004 | 36743 | 0.000 |
Why?
|